JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rollins, D. E.
Right arrow Articles by Woodbury, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rollins, D. E.
Right arrow Articles by Woodbury, D. M.
Journal of Pharmacology And Experimental Therapeutics, Vol. 174, Issue 3, 535-540, 1970
Copyright © 1970 by American Society for Pharmacology and Experimental Therapeutics


TISSUE ACID-BASE BALANCE IN ACETAZOLAMIDE-TREATED RATS

D. E. Rollins 1, C. D. Withrow 1, and D. M. Woodbury 1

1 Department of Pharmacology, University of Utah College of Medicine, Salt Lake City, Utah

Extracellular and intracellular acid-base parameters were measured in intact and nephrectomized rats treated with acetazolamide. Tissue cell pH values in muscle and brain were determined from both the distribution of CO2 and 5,5-dimethyloxazolidine-2,4-dione. It was found that acetazolamide produced a noncarbonic acidosis in intact animals, but caused a carbonic acid acidosis in nephrectomized animals. Despite the fall in extracellular pH caused by acetazolamide in intact animals, brain intracellular pH tended to rise. Muscle cell pH values did not change significantly in acetazolamide-treated intact or nephrectomized animals. The CO2 and 5,5-dimethyloxazolidine-2,4-dione methods gave qualitatively similar results in all experiments. It was concluded that the apparently small effect of acetazolamide on brain intracellular pH cannot be simply explained but may be a consequence of several factors including possible errors in the 5,5-dimethyloxazolidine-2,4-dione method when applied to brain intracellular acid-base studies after acetazolamide administration.

Submitted on January 19, 1970
Accepted on April 19, 1970







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1970 by the American Society for Pharmacology and Experimental Therapeutics.